Literature DB >> 23383874

Refractory cutaneous angiosarcoma successfully treated with sunitinib.

H-J Lu, P C-H Chen, C-C Yen, F-C Hsiao, C-H Tzeng, H Ma, C-Y Shiau, T-C Chao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23383874     DOI： 10.1111/bjd.12258

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  Vascular sarcomas.

Authors:  Vinod Ravi; Shreyaskumar Patel
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

Review 2.  Management of Cutaneous Angiosarcoma: an Update Review.

Authors:  Siwei Bi; Ai Zhong; Xiya Yin; Jingyi Li; Ying Cen; Junjie Chen
Journal:  Curr Treat Options Oncol       Date:  2022-02-19

3.  Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.

Authors:  Hans Prenen; Dominiek Smeets; Massimiliano Mazzone; Diether Lambrechts; Xavier Sagaert; Raf Sciot; Maria Debiec-Rychter
Journal:  Oncotarget       Date:  2015-11-03

4.  Endothelial cell malignancies: new insights from the laboratory and clinic.

Authors:  Michael J Wagner; Vinod Ravi; David G Menter; Anil K Sood
Journal:  NPJ Precis Oncol       Date:  2017-04-20

5.  Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.

Authors:  Jieshan Guan; Zhijie Luo; Zhiwei Xiao; Yubin Xie; Lizhu Lin
Journal:  BMC Cancer       Date:  2019-12-05       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.